Additionally, we found that inhibiting PFKFB3 can suppress IH angiogenesis and induce cell apoptosis, suggesting that targeting PFKFB3 may be a new therapeutic strategy for IH (Yang et al., 2023). Here, PFKFB3 is linked to isolated hemihyperplasia.